Bio-Rad Laboratories ROE 2010-2024 | BIO
Current and historical return on equity (ROE) values for Bio-Rad Laboratories (BIO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Bio-Rad Laboratories ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-06-30 | $-1.33B | $6.78B | -16.07% |
| 2024-03-31 | $-0.32B | $9.05B | -3.72% |
| 2023-12-31 | $-0.64B | $8.74B | -7.20% |
| 2023-09-30 | $-0.16B | $8.42B | -1.75% |
| 2023-06-30 | $-0.43B | $8.45B | -4.72% |
| 2023-03-31 | $-0.19B | $9.76B | -2.08% |
| 2022-12-31 | $-3.63B | $9.62B | -39.03% |
| 2022-09-30 | $-6.02B | $8.45B | -58.38% |
| 2022-06-30 | $-1.93B | $8.92B | -16.03% |
| 2022-03-31 | $-0.09B | $10.18B | -0.71% |
| 2021-12-31 | $4.25B | $13.69B | 33.22% |
| 2021-09-30 | $6.67B | $15.33B | 56.23% |
| 2021-06-30 | $4.05B | $11.60B | 39.63% |
| 2021-03-31 | $4.11B | $10.61B | 44.78% |
| 2020-12-31 | $3.81B | $9.88B | 47.16% |
| 2020-09-30 | $3.52B | $8.83B | 49.88% |
| 2020-06-30 | $1.95B | $7.35B | 31.73% |
| 2020-03-31 | $1.58B | $6.29B | 27.87% |
| 2019-12-31 | $1.76B | $5.76B | 33.11% |
| 2019-09-30 | $0.38B | $5.13B | 7.71% |
| 2019-06-30 | $0.90B | $5.49B | 18.76% |
| 2019-03-31 | $0.57B | $4.86B | 12.44% |
| 2018-12-31 | $0.37B | $4.02B | 8.09% |
| 2018-09-30 | $1.28B | $4.90B | 30.12% |
| 2018-06-30 | $1.03B | $4.64B | 27.64% |
| 2018-03-31 | $0.77B | $4.49B | 23.46% |
| 2017-12-31 | $0.12B | $2.93B | 4.32% |
| 2017-09-30 | $0.02B | $2.85B | 0.58% |
| 2017-06-30 | $0.01B | $2.81B | 0.44% |
| 2017-03-31 | $0.03B | $2.71B | 0.94% |
| 2016-12-31 | $0.03B | $2.58B | 0.96% |
| 2016-09-30 | $0.09B | $2.70B | 3.63% |
| 2016-06-30 | $0.09B | $2.62B | 3.69% |
| 2016-03-31 | $0.10B | $2.54B | 4.19% |
| 2015-12-31 | $0.11B | $2.49B | 4.60% |
| 2015-09-30 | $0.10B | $2.43B | 4.45% |
| 2015-06-30 | $0.10B | $2.36B | 4.35% |
| 2015-03-31 | $0.10B | $2.20B | 4.59% |
| 2014-12-31 | $0.09B | $2.19B | 4.07% |
| 2014-09-30 | $0.08B | $2.18B | 3.66% |
| 2014-06-30 | $0.06B | $2.25B | 2.82% |
| 2014-03-31 | $0.07B | $2.23B | 3.02% |
| 2013-12-31 | $0.08B | $2.19B | 3.71% |
| 2013-09-30 | $0.09B | $2.12B | 4.42% |
| 2013-06-30 | $0.14B | $2.07B | 7.00% |
| 2013-03-31 | $0.15B | $2.03B | 7.86% |
| 2012-12-31 | $0.17B | $2.02B | 8.64% |
| 2012-09-30 | $0.18B | $1.94B | 9.88% |
| 2012-06-30 | $0.19B | $1.85B | 10.38% |
| 2012-03-31 | $0.18B | $1.84B | 10.11% |
| 2011-12-31 | $0.18B | $1.74B | 10.57% |
| 2011-09-30 | $0.19B | $1.69B | 11.38% |
| 2011-06-30 | $0.19B | $1.73B | 11.79% |
| 2011-03-31 | $0.18B | $1.61B | 12.51% |
| 2010-12-31 | $0.19B | $1.54B | 13.35% |
| 2010-09-30 | $0.16B | $1.43B | 11.75% |
| 2010-06-30 | $0.15B | $1.30B | 11.74% |
| 2010-03-31 | $0.15B | $1.30B | 12.16% |
| 2009-12-31 | $0.15B | $1.28B | 12.36% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $9.247B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.617B | 25.27 |
| Stryker (SYK) | United States | $137.290B | 32.08 |
| Boston Scientific (BSX) | United States | $122.743B | 37.38 |
| Medtronic (MDT) | Ireland | $114.552B | 17.05 |
| EssilorLuxottica (ESLOY) | France | $108.842B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.651B | 35.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.030B | 0.00 |
| ResMed (RMD) | United States | $35.117B | 30.92 |
| Koninklijke Philips (PHG) | Netherlands | $30.774B | 23.39 |
| Terumo (TRUMY) | Japan | $28.517B | 40.27 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.039B | 13.87 |
| Baxter (BAX) | United States | $19.851B | 13.46 |
| Insulet (PODD) | United States | $16.269B | 68.45 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.605B | 0.00 |
| Demant (WILYY) | Denmark | $8.667B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.898B | 33.39 |
| Lantheus Holdings (LNTH) | United States | $7.454B | 17.89 |
| ICU Medical (ICUI) | United States | $4.261B | 40.67 |
| Haemonetics (HAE) | United States | $4.084B | 20.20 |
| TG Therapeutics (TGTX) | United States | $3.689B | 39.07 |
| Neogen (NEOG) | United States | $3.599B | 37.75 |
| Prestige Consumer Healthcare (PBH) | United States | $3.534B | 17.61 |
| GN Store Nord (GNNDY) | Denmark | $3.509B | 21.14 |
| Perrigo (PRGO) | Ireland | $3.499B | 11.06 |
| Envista Holdings (NVST) | United States | $3.398B | 18.13 |
| QuidelOrtho (QDEL) | United States | $3.063B | 19.30 |
| Agios Pharmaceuticals (AGIO) | United States | $2.595B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.226B | 37.36 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.124B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.061B | 54.92 |
| Warby Parker (WRBY) | United States | $1.614B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.497B | 10.81 |
| InMode (INMD) | Israel | $1.464B | 9.32 |
| AtriCure (ATRC) | United States | $1.372B | 0.00 |
| Owens & Minor (OMI) | United States | $1.247B | 9.63 |
| Verano Holdings (VRNOF) | United States | $1.184B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.123B | 0.00 |
| Evolus (EOLS) | United States | $1.006B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.894B | 18.55 |
| National Vision Holdings (EYE) | United States | $0.867B | 27.55 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Surmodics (SRDX) | United States | $0.549B | 116.64 |
| Quanterix (QTRX) | United States | $0.489B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.488B | 14.72 |
| Jin Medical (ZJYL) | China | $0.439B | 0.00 |
| ZimVie (ZIMV) | United States | $0.435B | 40.41 |
| Valneva SE (VALN) | France | $0.432B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.389B | 0.00 |
| Cerus (CERS) | United States | $0.324B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.324B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.320B | 8.25 |
| Aurora Cannabis (ACB) | Canada | $0.319B | 0.00 |
| Biote (BTMD) | United States | $0.307B | 14.18 |
| Viemed Healthcare (VMD) | United States | $0.283B | 30.38 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Zynex (ZYXI) | United States | $0.257B | 45.00 |
| Utah Medical Products (UTMD) | United States | $0.232B | 15.41 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.194B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.163B | 67.33 |
| FitLife Brands (FTLF) | United States | $0.153B | 20.64 |
| Brainsway (BWAY) | Israel | $0.135B | 161.40 |
| TriSalus Life Sciences (TLSI) | United States | $0.130B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.121B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.114B | 0.00 |
| Veru (VERU) | United States | $0.113B | 0.00 |
| Fonar (FONR) | United States | $0.111B | 11.44 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.80 |
| InterCure (INCR) | Israel | $0.087B | 14.62 |
| Zevia PBC (ZVIA) | United States | $0.083B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.082B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.071B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Exagen (XGN) | United States | $0.055B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.051B | 3.35 |
| Apyx Medical (APYX) | United States | $0.042B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 21.30 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |